Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Freshpet, Inc.FRPT · Entity 1637 | EVP, Treasurer | September 12, 2024 | September 16, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Freshpet, Inc.
Report date September 12, 2024 · Filed September 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 86,039 |
Ending reported balance
After 2024-09-12 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-09-12 · Exercise / conversion · Acquired 3,822 · Balance 89,861 Row 2 · 2024-09-12 · Sale · Disposed 3,822 · Balance 86,039 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.06. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4. |
| Options to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $49.77 · Expires 2029-10-01 | Direct | 5,500 |
Reported balance
After 2024-09-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-09-12 · Exercise / conversion · Disposed 3,822 · Balance 5,500 F2: The stock options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan, and vested on December 31, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.06. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
F2: The stock options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan, and vested on December 31, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2016 Filed Jan 4, 2017 23:02 UTC | Freshpet, Inc. FRPT · Entity 1637 | GrantOption to Purchase Common Stock · Derivative | 35,414 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001437749-17-000185 · rdgdoc.xml · derivative · entry 1 Macchiaverna Stephen · CIK 0001623800 · Sr. VP, Controller, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,414 Underlying: Common Stock · 35,414 shares Expires 2020-12-31 F1 · derivative.exercise_date: The options were originally issued pursuant to the Issuer's 2010 Stock Option Plan as performance based awards. On December 30, 2016, the awards were amended from performance based awards to time vested awards. The awards as amended vest on December 30, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.